{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:58:44Z","timestamp":1778630324833,"version":"3.51.4"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":1374,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031829","name":"Ceva Sante Animale","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031829","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Activity of the circulating renin-angiotensin-aldosterone system (RAAS) has not been comprehensively characterized in cats with systemic hypertension (SH) or cardiomyopathy (CM), and the effects of furosemide or amlodipine treatment on the RAAS have not been fully evaluated in cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>To document RAAS activity in cats with SH or CM compared to healthy cats and determine how RAAS profiles change with furosemide or amlodipine treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Sixty-six client-owned cats: 15 with SH (7 amlodipine-treated, 8 untreated), 17 with advanced CM (7 furosemide-treated, 10 not furosemide-treated), and 34 healthy cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Equilibrium concentrations of RAAS peptides and aldosterone were quantified in serum samples by liquid chromatography-mass spectrometry. Variables were compared between groups using Kruskal-Wallis analysis with post hoc Holms-corrected Dunn's testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with healthy cats, cats with CM had higher concentrations of angiotensin I, aldosterone, and plasma renin activity (all P\u00a0&amp;lt;\u2009.01), and these differences remained significant (P\u00a0&amp;lt;\u2009.03) after considering subgroups of untreated or furosemide-treated cats. Compared with healthy cats, untreated cats with SH showed no differences in RAAS biomarkers, whereas amlodipine-treated cats had higher concentrations of angiotensins I, II, III, IV, and 1-7, aldosterone, and plasma renin activity (all P\u00a0&amp;lt;\u2009.03). Multivariable analysis determined that furosemide and amlodipine treatments were independent predictors of increased RAAS biomarker concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Cats with CM had increased RAAS activity, whereas cats with untreated SH did not. Furosemide and amlodipine both led to nonspecific activation of both classical and alternative RAAS pathways in cats.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.16401","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T05:55:01Z","timestamp":1647237301000},"page":"897-909","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9153-7916","authenticated-orcid":false,"given":"Jessica L.","family":"Ward","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Iowa State University Department of Veterinary Clinical Sciences, , Ames, Iowa,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6892-4176","authenticated-orcid":false,"given":"Emilie","family":"Guillot","sequence":"additional","affiliation":[{"name":"Ceva Sant\u00e9 Animale, Companion Animal Franchise , Libourne,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Domenig","sequence":"additional","affiliation":[{"name":"Attoquant Diagnostics , Vienna,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2812-151X","authenticated-orcid":false,"given":"Wendy A.","family":"Ware","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Iowa State University Department of Veterinary Clinical Sciences, , Ames, Iowa,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingnan","family":"Yuan","sequence":"additional","affiliation":[{"name":"SMART Pharmacology, College of Veterinary Medicine, Iowa State University Department of Veterinary Biomedical Sciences, , Ames, Iowa,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P.","family":"Mochel","sequence":"additional","affiliation":[{"name":"SMART Pharmacology, College of Veterinary Medicine, Iowa State University Department of Veterinary Biomedical Sciences, , Ames, Iowa,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,5,1]]},"reference":[{"key":"2026020303582107600_jvim16401-bib-0001","article-title":"The renin-angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int J Inflam"},{"key":"2026020303582107600_jvim16401-bib-0002","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026020303582107600_jvim16401-bib-0003","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.CIR.100.11.1223","article-title":"Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis","volume":"100","author":"Tummala","year":"1999","journal-title":"Circulation"},{"key":"2026020303582107600_jvim16401-bib-0004","first-page":"2020","article-title":"Angiotensin II infusion-induced inflammation, monocytic fibroblast precursor infiltration, and cardiac fibrosis are pressure dependent","volume":"17","author":"Qi","year":"2011","journal-title":"Cardiovasc Toxicol"},{"key":"2026020303582107600_jvim16401-bib-0005","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"2026020303582107600_jvim16401-bib-0006","first-page":"375","article-title":"Advances in management of acute hypertension: a concise review","volume":"13","author":"Tulman","year":"2012","journal-title":"Discov Med"},{"key":"2026020303582107600_jvim16401-bib-0007","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"2026020303582107600_jvim16401-bib-0008","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESHGuidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2026020303582107600_jvim16401-bib-0009","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2460\/ajvr.69.3.343","article-title":"Evaluation of the renin-angiotensin system in cardiac tissue of cats with pressure-overload cardiac hypertrophy","volume":"69","author":"Uechi","year":"2008","journal-title":"Am J Vet Res"},{"key":"2026020303582107600_jvim16401-bib-0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1939-1676.2006.tb00707.x","article-title":"The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure","volume":"20","author":"MacDonald","year":"2006","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0011","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2460\/ajvr.1997.58.05.535","article-title":"Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease","volume":"58","author":"Jensen","year":"1997","journal-title":"Am J Vet Res"},{"key":"2026020303582107600_jvim16401-bib-0012","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/jvim.12240","article-title":"Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate","volume":"28","author":"Jepson","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0013","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jvim.12062","article-title":"Renin-angiotensin-aldosterone system activity in hyperthyroid cats with and without concurrent hypertension","volume":"27","author":"Williams","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0014","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jvp.12154","article-title":"Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs","volume":"38","author":"Lantis","year":"2015","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303582107600_jvim16401-bib-0015","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1939-1676.2009.0367.x","article-title":"Acute effect of pimobendan and furosemide on the circulating renin-angiotensin-aldosterone system in healthy dogs","volume":"23","author":"Sayer","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0016","article-title":"AMODIP: Summary of Product Characteristics","year":"2015"},{"key":"2026020303582107600_jvim16401-bib-0017","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/jvim.15331","article-title":"ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats","volume":"32","author":"Acierno","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0018","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/1098612X17693500","article-title":"ISFM consensus guidelines on the diagnosis and management of hypertension in cats","volume":"19","author":"Taylor","year":"2017","journal-title":"J Feline Med Surg"},{"key":"2026020303582107600_jvim16401-bib-0019","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2885.2007.00894.x","article-title":"The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog","volume":"30","author":"Atkins","year":"2007","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303582107600_jvim16401-bib-0020","doi-asserted-by":"crossref","DOI":"10.1177\/1470320316633897","article-title":"Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition","volume":"17","author":"Ames","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026020303582107600_jvim16401-bib-0021","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1476-5381.1996.tb15735.x","article-title":"Effect of amlodipine on renin secretion and renin gene expression in rats","volume":"119","author":"Schricker","year":"1996","journal-title":"Br J Pharmacol"},{"key":"2026020303582107600_jvim16401-bib-0022","article-title":"Renin-angiotensin-aldosterone system activation in hypertensive cats receiving amlodipine","volume":"34","author":"Atkins","year":"2020","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0023","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1210\/endo.131.4.1396304","article-title":"Effects of angiotensin converting enzyme inhibition, sodium depletion, calcium, isoproterenol, and angiotensin II on renin secretion by individual renocortical cells","volume":"131","author":"Geary","year":"1992","journal-title":"Endocrinology"},{"key":"2026020303582107600_jvim16401-bib-0024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijcard.2005.02.016","article-title":"Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition","volume":"106","author":"Van de Wal","year":"2006","journal-title":"Int J Cardiol"},{"key":"2026020303582107600_jvim16401-bib-0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin system revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0026","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/euhj.1999.1740","article-title":"Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure","volume":"21","author":"Roig","year":"2000","journal-title":"Eur Heart J"},{"key":"2026020303582107600_jvim16401-bib-0027","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2885.2012.01406.x","article-title":"Capturing the dynamics of systemic renin-angiotensin-aldosterone system (RAAS) peptides heightens the understanding of the effect of benazepril in dogs","volume":"36","author":"Mochel","year":"2013","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303582107600_jvim16401-bib-0028","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s11095-014-1587-9","article-title":"Pharmacokinetic\/pharmacodynamic modeling of renin-angiotensin aldosterone biomarkers following angiotensin-converting enzyme (ACE) inhibition therapy with benazepril in dogs","volume":"32","author":"Mochel","year":"2015","journal-title":"Pharm Res"},{"key":"2026020303582107600_jvim16401-bib-0029","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/jvp.12017","article-title":"Response to letter from Atkins et al. re: Capturing the dynamics of systemic renin-angiotensin-aldosterone system (RAAS) peptides heightens the understanding of the effect of benazepril in dogs","volume":"35","author":"Mochel","year":"2012","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303582107600_jvim16401-bib-0030","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/jvim.15833","article-title":"Vitamin D status in cats with cardiomyopathy","volume":"34","author":"Ware","year":"2020","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0031","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/jvim.15745","article-title":"ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats","volume":"34","author":"Luis Fuentes","year":"2020","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0032","doi-asserted-by":"crossref","DOI":"10.1038\/srep33678","article-title":"Neprilysin is a mediator of alternative renin-angiotensin-system activation in the murine and human kidney","volume":"6","author":"Domenig","year":"2016","journal-title":"Sci Rep"},{"key":"2026020303582107600_jvim16401-bib-0033","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jvim.15948","article-title":"Effect of angiotensin receptor blockers and angiotensin-converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease","volume":"35","author":"Huh","year":"2021","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0034","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/clinchem\/hvaa001","article-title":"Measurement of equilibrium angiotensin II in the diagnosis of primary aldosteronism","volume":"66","author":"Guo","year":"2020","journal-title":"Clin Chem"},{"key":"2026020303582107600_jvim16401-bib-0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1373\/clinchem.2017.278705","article-title":"Low- and high-renin heart failure phenotypes with clinical implications","volume":"64","author":"Pavo","year":"2018","journal-title":"Clin Chem"},{"key":"2026020303582107600_jvim16401-bib-0036","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/HYPERTENSIONAHA.119.13772","article-title":"Renin-angiotensin-aldosterone system triple-A analysis for the screening of primary aldosteronism","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"key":"2026020303582107600_jvim16401-bib-0037","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"key":"2026020303582107600_jvim16401-bib-0038","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/011542650802300176","article-title":"Biostatistics primer: part 2","volume":"23","author":"Overholser","year":"2008","journal-title":"Nutr Clin Pract"},{"key":"2026020303582107600_jvim16401-bib-0039","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2460\/ajvr.76.12.1041","article-title":"Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs","volume":"76","author":"Ames","year":"2015","journal-title":"Am J Vet Res"},{"key":"2026020303582107600_jvim16401-bib-0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2460\/ajvr.74.8.1084","article-title":"Effect of furosemide and high-dosage pimobendan administration on the renin-angiotensin-aldosterone system in dogs","volume":"74","author":"Ames","year":"2013","journal-title":"Am J Vet Res"},{"key":"2026020303582107600_jvim16401-bib-0041","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jvp.12216","article-title":"The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs","volume":"38","author":"Lantis","year":"2015","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303582107600_jvim16401-bib-0042","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jvc.2019.11.003","article-title":"Comparison between the effects of torsemide and furosemide on the renin-angiotensin-aldosterone system of normal dogs","volume":"26","author":"Potter","year":"2019","journal-title":"J Vet Cardiol"},{"key":"2026020303582107600_jvim16401-bib-0043","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1681\/ASN.2016070734","article-title":"Physiology and pathophysiology of the intrarenal renin-angiotensin system: an update","volume":"28","author":"Yang","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026020303582107600_jvim16401-bib-0044","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.amjhyper.2007.02.018","article-title":"The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension","volume":"20","author":"van den Born","year":"2007","journal-title":"Am J Hypertens"},{"key":"2026020303582107600_jvim16401-bib-0045","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1939-1676.2002.tb01259.x","article-title":"Echocardiographic and radiographic changes associated with systemic hypertension in cats","volume":"16","author":"Nelson","year":"2002","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0046","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5326\/0400359","article-title":"Spectrum of M-mode echocardiographic abnormalities in 75 cats with systemic hypertension","volume":"40","author":"Henik","year":"2004","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303582107600_jvim16401-bib-0047","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1939-1676.2001.tb02299.x","article-title":"Effect of amlodipine on echocardiographic variables in cats with systemic hypertension","volume":"15","author":"Snyder","year":"2001","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0048","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1939-1676.2003.tb01328.x","article-title":"Spontaneous feline hypertension: clinical and echocardiographic abnormalities, and survival rate","volume":"17","author":"Chetboul","year":"2003","journal-title":"J Vet Intern Med"},{"key":"2026020303582107600_jvim16401-bib-0049","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cvsm.2009.10.005","article-title":"Endocrine hypertension in small animals","volume":"40","author":"Reusch","year":"2010","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303582107600_jvim16401-bib-0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ng.384","article-title":"Genome-wide association study of blood pressure and hypertension","volume":"41","author":"Levy","year":"2009","journal-title":"Nat Genet"},{"key":"2026020303582107600_jvim16401-bib-0051","first-page":"457","article-title":"Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis","volume":"82","author":"Fiad","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2026020303582107600_jvim16401-bib-0052","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"2026020303582107600_jvim16401-bib-0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005406","article-title":"Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation","volume":"4","author":"Esteban","year":"2009","journal-title":"PLoS One"},{"key":"2026020303582107600_jvim16401-bib-0054","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20110036","article-title":"Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors","volume":"121","author":"Bosnyak","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"2026020303582107600_jvim16401-bib-0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jvim.16025","article-title":"Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease","volume":"35","author":"Larouche-Lebel","year":"2021","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.16401","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.16401","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/36\/3\/897\/66666185\/jvim16401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/36\/3\/897\/66666185\/jvim16401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:58:34Z","timestamp":1770109114000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/36\/3\/897\/8449064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.16401","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5]]},"published":{"date-parts":[[2022,5,1]]},"assertion":[{"value":"2021-09-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}